Belgium · Biotechnology startup
Belgium · ExeVir Bio
ExeVir Bio is a Belgium-based company that develops single-domain antibody-based therapies that help patients ward off viral infections.
Funding reportedLast round: Grant
What company datasets say ExeVir Bio raised
Funding, as reported
Reported in all68.6Min the source's currency
Rounds3
Last roundGrant
Last round dateJun 2023
Investors listed11
Founders and team
From ExeVir Bio's own website: 2 on the team.
- Mike GarrettChief Executive Officer
- Viki BockstalChief Scientific Officer
On 2 portfolio pages
Investors who name them
Each firm lists ExeVir Bio on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in Belgium
Startups like it
Is this your company?
Add your raise, your deck and your story, and put ExeVir Bio in front of investors. Or tell us what we have wrong.